Youwen Zhu

Sep 8, 2024 | onlinelibrary.wiley.com | Kun Liu |Youwen Zhu |Shan Li |Hong Zhu

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.

Mar 12, 2024 | onlinelibrary.wiley.com | Kun Liu |Youwen Zhu |Hong Zhu |Manting Zeng

1 INTRODUCTION Lung cancer is the deadliest and second most common form of cancer in the USA, with approximately 238,340 diagnoses and 127,070 deaths forecast in 2023 alone.1 Non-small cell lung cancer (NSCLC) patients comprise 85% of the lung cancer patient population, and roughly 70% of these patients are initially diagnosed only when the disease is locally advances or metastatic, exhibiting a 5-year overall survival (OS) rate of just 26%.2, 3 Only one in four NSCLC patients are eligible...

Aug 17, 2023 | onlinelibrary.wiley.com | Youwen Zhu |Kun Liu |Hong Zhu

aBTC advanced biliary tract cancer AEs adverse events AIC the Akaike information criteria BIC the Bayesian information criteria BSC best supportive care BTC biliary tract cancer CHEERS 2022 The Consolidated Health Economic Evaluation Reporting Standards 2022 CI confidence interval CPI consumer price index ECC extrahepatic cholangiocarcinoma GBC gallbladder cancer GemCis gemcitabine and cisplatin HR hazard ratio ICC intrahepatic cholangiocarcinoma ICER incremental cost-effectiveness ratio ICIs...